Insider Trades33 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 12,000 | $9.24 | $859.0M | -22.73% | +582.00% | $110.9K | -6.22% | — | Buy Now |
| May 18, 2026 | Sell | REPL | Emily Luisa Hill | Chief Financial Officer | 7,812 | $5.08 | $859.0M | -22.73% | +582.00% | $39.7K | -3.20% | — | Buy Now |
| May 18, 2026 | Sell | REPL | Andrew Schwendenman | Chief Accounting Officer | 7,894 | $5.08 | $859.0M | -22.73% | +582.00% | $40.1K | -6.87% | — | Buy Now |
| May 18, 2026 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 8,626 | $5.08 | $859.0M | -22.73% | +582.00% | $43.8K | -4.28% | — | Buy Now |
| May 18, 2026 | Sell | REPL | Konstantinos Xynos | Chief Medical Officer | 14,023 | $5.08 | $859.0M | -22.73% | +582.00% | $71.2K | -5.62% | — | Buy Now |
| May 18, 2026 | Sell | REPL | Sushil Patel | Chief Executive Officer | 37,324 | $5.08 | $859.0M | -22.73% | +582.00% | $189.6K | -4.76% | — | Buy Now |
| Apr 2, 2026 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 6,500 | $8.01 | $859.0M | -22.73% | +582.00% | $52.1K | -4.11% | 10b5-1 | Buy Now |
| Dec 2, 2025 | Sell | REPL | Sushil Patel | Chief Executive Officer | 10,000 | $11.13 | $859.0M | -22.73% | +582.00% | $111.3K | -2.91% | 10b5-1 | Buy Now |
| Nov 17, 2025 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 5,208 | $9.10 | $859.0M | -22.73% | +582.00% | $47.4K | -4.06% | — | Buy Now |
| Nov 17, 2025 | Sell | REPL | Konstantinos Xynos | Chief Medical Officer | 7,248 | $9.10 | $859.0M | -22.73% | +582.00% | $66.0K | -4.93% | — | Buy Now |
| Aug 15, 2025 | Sell | REPL | Emily Luisa Hill | Chief Financial Officer | 9,154 | $5.37 | $859.0M | -22.73% | +582.00% | $49.2K | -6.38% | — | Buy Now |
| May 20, 2025 | Sell | REPL | Emily Luisa Hill | Chief Financial Officer | 2,535 | $8.05 | $859.0M | -22.73% | +582.00% | $20.4K | -1.74% | — | Buy Now |
| May 20, 2025 | Sell | REPL | Andrew Schwendenman | Chief Accounting Officer | 3,287 | $8.05 | $859.0M | -22.73% | +582.00% | $26.5K | -4.59% | — | Buy Now |
| May 20, 2025 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 3,749 | $8.05 | $859.0M | -22.73% | +582.00% | $30.2K | -2.84% | — | Buy Now |
| May 20, 2025 | Sell | REPL | Konstantinos Xynos | Chief Medical Officer | 7,952 | $8.06 | $859.0M | -22.73% | +582.00% | $64.1K | -5.13% | — | Buy Now |
| May 20, 2025 | Sell | REPL | Sushil Patel | Chief Executive Officer | 25,105 | $8.06 | $859.0M | -22.73% | +582.00% | $202.3K | -6.81% | — | Buy Now |
| Dec 16, 2024 | Sell | REPL | Sushil Patel | Chief Executive Officer | 10,000 | $12.42 | $859.0M | -22.73% | +582.00% | $124.2K | -4.72% | 10b5-1 | Buy Now |
| Nov 18, 2024 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 5,207 | $10.78 | $859.0M | -22.73% | +582.00% | $56.1K | -5.64% | — | Buy Now |
| Nov 18, 2024 | Sell | REPL | Konstantinos Xynos | Chief Medical Officer | 7,246 | $10.78 | $859.0M | -22.73% | +582.00% | $78.1K | -6.19% | — | Buy Now |
| Aug 30, 2024 | Sell | REPL | Philip Astley-Sparke | Executive Chairman | 50,000 | $10.17 | $859.0M | -22.73% | +582.00% | $508.5K | -3.36% | — | Buy Now |
| Aug 16, 2024 | Sell | REPL | Emily Luisa Hill | Chief Financial Officer | 8,938 | $10.18 | $859.0M | -22.73% | +582.00% | $91.0K | -8.13% | — | Buy Now |
| Jun 7, 2024 | Sell | REPL | Konstantinos Xynos | Chief Medical Officer | 15,881 | $7.50 | $859.0M | -22.73% | +582.00% | $119.1K | -11.94% | 10b5-1 | Buy Now |
| May 16, 2024 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 2,218 | $6.47 | $859.0M | -22.73% | +582.00% | $14.4K | -2.35% | — | Buy Now |
| May 16, 2024 | Sell | REPL | Andrew Schwendenman | Chief Accounting Officer | 2,298 | $6.47 | $859.0M | -22.73% | +582.00% | $14.9K | -5.67% | — | Buy Now |
| May 16, 2024 | Sell | REPL | Konstantinos Xynos | Chief Medical Officer | 6,367 | $6.47 | $859.0M | -22.73% | +582.00% | $41.2K | -4.57% | — | Buy Now |
| May 16, 2024 | Sell | REPL | Colin Love | Chief Operating Officer | 17,615 | $6.47 | $859.0M | -22.73% | +582.00% | $114.0K | -2.22% | — | Buy Now |
| May 16, 2024 | Sell | REPL | Sushil Patel | Chief Executive Officer | 20,194 | $6.47 | $859.0M | -22.73% | +582.00% | $130.7K | -8.70% | — | Buy Now |
| May 16, 2024 | Sell | REPL | Philip Astley-Sparke | Executive Chairman | 37,928 | $6.47 | $859.0M | -22.73% | +582.00% | $245.4K | -2.49% | — | Buy Now |
| Nov 16, 2023 | Sell | REPL | Christopher Sarchi | Chief Commercial Officer | 5,255 | $10.92 | $859.0M | -22.73% | +582.00% | $57.4K | -6.78% | — | Buy Now |
| Nov 16, 2023 | Sell | REPL | Konstantinos Xynos | Chief Medical Officer | 7,313 | $10.92 | $859.0M | -22.73% | +582.00% | $79.9K | -6.09% | — | Buy Now |
| Sep 11, 2023 | Sell | REPL | Pamela Esposito | Chief Business Officer | 11,316 | $11.65 | $859.0M | -22.73% | +582.00% | $131.9K | +0.00% | 10b5-1 | Buy Now |
| Aug 22, 2023 | Sell | REPL | Pamela Esposito | Chief Business Officer | 37,200 | $13.29 | $859.0M | -22.73% | +582.00% | $494.6K | +0.00% | 10b5-1 | Buy Now |
| Aug 11, 2023 | Sell | REPL | Pamela Esposito | Chief Business Officer | 2,800 | $11.65 | $859.0M | -22.73% | +582.00% | $32.6K | +0.00% | 10b5-1 | Buy Now |